All the news Showing 10 of 178 articles from: Finance, funding & health economicsGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Bulgarian Harm Reduction Drown in Bureaucracy: Interview with Yuliya Georgieva Drug Reporter / 07 December 2018 When we find a cure, price it like Netflix to ensure access The Hill / 13 August 2018 Merck To Steeply Cut Price of Hepatitis C Drug Zepatier Managed Care Magazine / 22 July 2018 Novel Medicaid Strategy Proposed to Increase Access to HCV Treatment Infectious Disease Advisor / 29 May 2018 Medicines Excitement in the Netherlands – New Health Minister announces firm action on “absurd” medicines pricing Medicines Law & Policy / 27 November 2017 ‘Think outside the box’ to finance HCV elimination Healio / 22 November 2017 Eliminating viral hepatitis: time to match visions with action The Lancet (editorial) / 10 November 2017 MSF secures generic hepatitis C treatment at $120 compared to $147,000 launch price tag MSF press release / 31 October 2017 UK pharma denied legal challenge to drugs bill cap Pharmaphorum / 05 October 2017 Hepatitis C Drug’s Lower Cost Paves Way For Medicaid, Prisons To Expand Treatment Kaiser Health News / 05 October 2017 ← Prev12345...18Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Access to medicines & diagnostics Hepatitis C elimination Models of care Finance, funding & health economics National policy European policy International policy Activism and civil society Pharmaceutical industry Social issues Conference news Email bulletin archive